| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/03/2006 | WO2006081418A2 Ephb receptor-binding peptides |
| 08/03/2006 | WO2006080920A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/03/2006 | WO2006080837A2 Means and methods for breaking noncovalent binding interactions between molecules |
| 08/03/2006 | WO2006080625A1 Novel peptide isolated from aspergillus nidulans and pharmaceutical composition containing the same |
| 08/03/2006 | WO2006080483A1 Novel dendritic cell membrane molecule and dna encoding the same |
| 08/03/2006 | WO2006080017A2 Biologically active silver-coated proteins |
| 08/03/2006 | WO2006079565A2 Leishmania antigens suitable for a diagnostic kit of leishmania |
| 08/03/2006 | WO2006079176A1 Molecules and chimeric molecules thereof |
| 08/03/2006 | WO2006079169A1 Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes |
| 08/03/2006 | WO2006079155A1 Molecules and chimeric molecules thereof |
| 08/03/2006 | WO2006065821A3 Improved dna immunization with recombinase/transposase |
| 08/03/2006 | WO2006060799A3 Protein biomarkers and therapeutic targets in an animal model for amyotrophic lateral sclerosis |
| 08/03/2006 | WO2006058620A3 Method for producing carboxy-terminal amidified peptides |
| 08/03/2006 | WO2006054096A3 Soluble bifunctional proteins |
| 08/03/2006 | WO2006052363A3 Co-expression of multiple protein chains or subunits |
| 08/03/2006 | WO2006048768A3 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 08/03/2006 | WO2006048657A3 Fras related protein |
| 08/03/2006 | WO2006037960A3 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents |
| 08/03/2006 | WO2006037038B1 Optimized vaccines to provide protection against ebola and other viruses |
| 08/03/2006 | WO2006026667A3 Recombinant mva viruses expressing glade a/g, clade b, and clade c modified hiv, gag and pol genes |
| 08/03/2006 | WO2006023665A3 Il-1 antagonist formulations |
| 08/03/2006 | WO2006023148A3 Genetically modified human natural killer cell lines |
| 08/03/2006 | WO2006015368A9 Molecules with effects on cellular development and function |
| 08/03/2006 | WO2006005473A3 Rat trace amine associated receptors |
| 08/03/2006 | WO2006001911A3 Crystal structure of the hepatocyte growth factor beta chain and methods of use |
| 08/03/2006 | WO2005117940A9 Cell death modulation via antagonists of fasl and fas activation |
| 08/03/2006 | WO2005116655A3 Natriuretic compounds, conjugates, and uses thereof |
| 08/03/2006 | WO2005113774A3 Methods for production of xylitol in microorganisms |
| 08/03/2006 | WO2005112988A3 Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1) |
| 08/03/2006 | WO2005112628A3 Sptrx-3 polypeptide and nucleic acid. uses thereof in methods and compositions for evaluation of male fertility |
| 08/03/2006 | WO2005108428A3 Cd40 splice variants and their uses |
| 08/03/2006 | WO2005103715A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 08/03/2006 | WO2005097195A3 Methods of reducing aggregation of il-1ra |
| 08/03/2006 | WO2005091753A3 Flexible vaccine assembly and vaccine delivery platform |
| 08/03/2006 | WO2005085288A3 Natural igm antibodies and inhibitors thereof |
| 08/03/2006 | WO2005069900B1 Npc1l1 (npc3) and methods of identifying ligands thereof |
| 08/03/2006 | WO2005058942A8 Refolded membrane protein in monodisperse form |
| 08/03/2006 | WO2005049651A3 Cancer diagnosis and therapy |
| 08/03/2006 | WO2005001044A3 Compositions related to pleiotrophin methods and uses thereof |
| 08/03/2006 | WO2004060867A3 Secreted protein factor and cell membrane-bound splice variant |
| 08/03/2006 | WO2004058171A3 Antibodies against gpr64 and uses thereof |
| 08/03/2006 | WO2004039951A3 Il-1 receptor based antagonists and methods of making and using |
| 08/03/2006 | WO2004034974A3 Anti-reg iϝ antibody for treatment of colon cancer |
| 08/03/2006 | WO2004009614A3 Receptor (sstr4)- selective somatostatin analogs |
| 08/03/2006 | WO2004001381A8 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/03/2006 | WO2003072041A3 Assays to monitor amyloid precursor protein processing |
| 08/03/2006 | WO2003014318A3 Methods for treating diabetes and other blood sugar disorders |
| 08/03/2006 | WO2003013425A3 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 08/03/2006 | WO2002102319A3 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue |
| 08/03/2006 | US20060174373 by expressing a polypeptide from yeast that when expressed will increase the total amount of oil (i.e. triacylglycerols TAG) that is produced in transgenic organisms |
| 08/03/2006 | US20060174372 Plants transformed with polynucleotides encoding broad-spectrum delta-endotoxins |
| 08/03/2006 | US20060174370 A 16 base pair polynucleotide sequence of Arabidopsis thaliana is a genetic insulator that can effectively isolate a transgene from positional effects of neighboring gene activities in transgenic plant cells |
| 08/03/2006 | US20060174361 Transgenic mice containing adrenocorticotropin hormone receptor gene disruptions |
| 08/03/2006 | US20060174357 Gene expression in mammary glands of genetic engineered animals whose genome comprises DNA segments linked to regulatory sequences that code for fibrinopeptide fragments, then collecting and recovering fibronopeptides from dairy products |
| 08/03/2006 | US20060174354 Hcv gene transgenic animal |
| 08/03/2006 | US20060173169 Method and system for corn fractionation |
| 08/03/2006 | US20060173168 Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
| 08/03/2006 | US20060173167 Process for the purification of recombinant polypeptides |
| 08/03/2006 | US20060173166 Protein lattice |
| 08/03/2006 | US20060173165 Comprises successively in 5'-3' direction a nucleotide sequence encoding the dipeptide Asp-Pro and a nucleotide sequence encoding a toxic protein; for overexpressing recombinant proteins with or without fusion to a soluble protein |
| 08/03/2006 | US20060173164 Purified nucleic acid sequence encoding a fusion protein comprising target peptide linked to a fusion carrier protein; carrier protein acts to promote the overexpression of peptide-protein fusion in the form of inclusion bodies, which minimizes in-cell proteolysis of peptides; nuclear magnetic resonance |
| 08/03/2006 | US20060173162 Bactericidak anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) |
| 08/03/2006 | US20060173159 Water-soluble thioester and selenoester compounds and methods for making and using the same |
| 08/03/2006 | US20060172958 Phospholipid scramblase 3 |
| 08/03/2006 | US20060172948 Gamma-carboxyglutamate containing conopeptides |
| 08/03/2006 | US20060172947 Physiologically active peptides and drugs containing the same |
| 08/03/2006 | US20060172946 Having serine protease inhibitory activity |
| 08/03/2006 | US20060172943 Restoring vascular function |
| 08/03/2006 | US20060172942 Process for producing polypeptide mixtures using hydrogenolysis |
| 08/03/2006 | US20060172941 Antiproliferative agents; prevent binding of rndothelial growth factor to receptor; anticancer agents; leukemia; antiinflammatory agents; skin disorders |
| 08/03/2006 | US20060172940 Glycosylated mucocidin antimicrobial peptide, ophthalmic formulation, inhibiting microbial growth |
| 08/03/2006 | US20060172937 Relates to peptides which bind to MHC molecules of either Class I or Class II; the peptides consist of amino acid sequences found in the NY-ESO-1 molecule; useful in treating cancerous conditions |
| 08/03/2006 | US20060172933 Natriuretic compounds, conjugates, and uses thereof |
| 08/03/2006 | US20060172932 Novel erythropoietin receptor agonists |
| 08/03/2006 | US20060172931 Heparin-binding peptides and uses thereof |
| 08/03/2006 | US20060172930 Apoptosis-inducing gene and utilization of the same |
| 08/03/2006 | US20060172928 providing a biomolecule such as nucleic acid, protein, antibody immobilized on a substrate (quartz, glass etc) covering with a nonreducing disaccharide trehalose or sucrose; a protein or peptide of Late Embryogenesis Abundant (LEA) class comprising a motif of 11 amino acids; biochip; storage stability |
| 08/03/2006 | US20060172927 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 08/03/2006 | US20060172424 Methods for enhancing expression of recombinant proteins |
| 08/03/2006 | US20060172423 New expression system from rhodococcus |
| 08/03/2006 | US20060172419 Highly efficient gene targeting vectors and methods for gene targeting method forward epithelial cell line |
| 08/03/2006 | US20060172413 Transgenic mice containing melanocyte stimulating hormone receptor gene disruptions |
| 08/03/2006 | US20060172404 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 08/03/2006 | US20060172391 BMP-11 compositions |
| 08/03/2006 | US20060172389 Canine erythropoietin gene and recombinant protein |
| 08/03/2006 | US20060172388 Methods for enhancing expression of recombinant proteins |
| 08/03/2006 | US20060172387 Thermostability, better stability against proteolysis, better charge properties (for example lower pl) compared to native avidin and avidin-related proteins |
| 08/03/2006 | US20060172386 Human FGF-20 gene and gene expression products |
| 08/03/2006 | US20060172385 Methods for producing soluble membrane-spanning proteins |
| 08/03/2006 | US20060172384 FGF18 production in prokaryotic hosts |
| 08/03/2006 | US20060172381 Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins |
| 08/03/2006 | US20060172380 TAB1 protein and DNA coding therefore |
| 08/03/2006 | US20060172376 Method and device for the continuous production of biomolecules |
| 08/03/2006 | US20060172360 Mkk7 activation inhibitor |
| 08/03/2006 | US20060172359 Identifying prions in infectious conformations in mammalian nervous system tissue; diagnosing spongiform encephalopathies in animals |
| 08/03/2006 | US20060172355 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172354 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172352 Nuclear matrix proteins |
| 08/03/2006 | US20060172348 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 08/03/2006 | US20060172346 Methods of designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteins |